搜索筛选:
搜索耗时0.1031秒,为你在为你在102,285,761篇论文里面共找到 24 篇相符的论文内容
发布年度:
[期刊论文] 作者：Xiaofei Wang,Baohui Han,
来源：癌症治疗(英文) 年份：2013
With the advances in surgery, chemotherapy, and radiotherapy over the last decades, the treatment strategies of lung cancer has been largely changed. In this re...
[期刊论文] 作者：Runbo Zhong Baohui Han Bo Jin,
来源：中国肿瘤临床：英文版 年份：2008
Following concurrent radio-chemotherapy or first-line chemotherapy for advanced non-small cell lung cancer (NSCLC),continuous maintenance therapy given to patie...
[期刊论文] 作者：Runbo Zhong,Baohui Han,Bo Jin,
来源：中国肿瘤临床（英文版） 年份：2004
ABSTRACT Following concurrent radio-chemotherapy or first-line chemotherapy for advanced non-small cell lung cancer(NSCLC), continuous maintenance therapy given...
[会议论文] 作者：Baohui Han,Tianqing Chu,Kai Li,
来源：2019中国肿瘤学大会 年份：2019
...
A multicenter randomized phase Ⅲ study of Polymeric micelle paclitaxel(pm-Pac)/cisplatin compared wi
[会议论文] 作者：Baohui Han,Qi Shimei,Yilong Wu,
来源：2019中国肿瘤学大会 年份：2019
Objective Background: Paclitaxel/cisplatin is one of the standard chemotherapies for non–small cell lung carcinoma.However,the solvents related adverse effects such as severe allergic reaction,histami...
[会议论文] 作者：Xiao fei Wang,Yun Feng,Bei li Gao,Baohui Han,
来源：2014中华医学会呼吸病学年会暨第十五次全国呼吸病学学术会议 年份：2014
...
A Clinical Study: ERCC1 Protein as a Guide for Individualized Therapy of Late-Stage Advanced Non-Sma
[会议论文] 作者：Zhiqiang Gao,Baohui Han,Jie Shen,Aiqin Gu,Liyan Jiang,
来源：中华医学会呼吸病学年会——2013第十四次全国呼吸病学学术会议 年份：2013
Excision repair cross-complementation group 1 (ERCC 1) protein has been associated with cisplatin resistance .The objective of this study was to investigate the correlation between the ERCC1 protein l...
[期刊论文] 作者：马美丽,沈洁,姜丽岩,Baohui Han,Hao Bai,,
来源：中德临床肿瘤学杂志 年份：2006
Objective: To investigate the prognostic factors for stage Ⅳ non-small cell lung cancer (NSCLC) with distant metastasis and establish a reliable model of clini...
[期刊论文] 作者：Aiqin Gu,Chunlei Shi,Liwen Xiong,Tianqing Chu,Jun Pei,Baohui Han,,
来源：Chinese Journal of Cancer Research 年份：2013
Objective: To evaluate the efficacy and safety of icotinib hydrochloride in patients with advanced non-small cell lung cancer (NSCLC). Methods: A total of 89 pa...
[会议论文] 作者：Aiqin Gu,Jianhong Lu,Weimin Wang,Chunlei Shi,Baohui Han,Ming Yao,
来源：华东地区第十四届实验动物科学学术交流会 年份：2016
The malignancy of non-small cell lung cancer (NSCLC) is largely due to its invasion.Hence,prevention of the cancer cell invasion,which is essentially regulated by vascular endothelial growth factor A...
[会议论文] 作者：Yuqing Lou,Rong Li,Liwen Xiong,Xueyan Zhang,Ping Gu,Baohui Han,
来源：中华医学会呼吸病学年会——2013第十四次全国呼吸病学学术会议 年份：2013
Aims No clear consensus has been reached on the NAD(P)H: quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer risk.We performed a meta-analysis to summarize the possible association...
Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with non-spe
[会议论文] 作者：Huizhen Yang,Shenglan Wang,Jiajun Teng,Runbo Zhong,Baohui Han,Jiayuan Sun,Lijun Ma,
来源：2014中华医学会呼吸病学年会暨第十五次全国呼吸病学学术会议 年份：2014
...
Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with non-spe
[会议论文] 作者：Huizhen Yang,Shenglan Wang,Jiajun Teng,Runbo Zhong,Baohui Han,Jiayuan Sun,Lijun Ma,
来源：2014中华医学会呼吸病学年会暨第十五次全国呼吸病学学术会议 年份：2014
Background and objective Endobronchial ultrasound-guidedtransbronchial needle aspiration (EBUS-TBNA) has emerged as a minimally invasive technique used for diagnosing intrathoracic malignancies as wel...
Determining the prevalence of EGFR mutations in patients with advanced non-small-cell lung cancer (a
[会议论文] 作者：Baohui Han,Chunlei Shi,Meng-zhao Wang,Yong He,Yi-ping Zhang,Sergei Tjulandin,Rose Mccormack,Marianne,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: IGNITE (a large, multinational, diagnostic, non-comparative, interventional study;NCT01788163) assessed EGFR mutation frequency in patients with...
Determining the prevalence of EGFR mutations in patients with advanced non-small-cell lung cancer (a
[会议论文] 作者：Chunlei Shi,Meng-zhao Wang,Yong He,Yi-ping Zhang,Sergei Tjulandin,Marianne Ratcliffe,Rose Mccormack,Baohui Han,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: IGNITE (a large, multinational, diagnostic, non-comparative, interventional study;NCT01788163) assessed EGFR mutation frequency in patients with advanced NSCLC of adenocarcinoma (ADC)/non-A...
[会议论文] 作者：Jun Pei,Baohui Han,Tianqing Chu,Minhua Shao,Jiajun Teng,Huifang Sha,Aiqing Gu,Rong Li,Jialin Qian,Weifeng,
来源：中华医学会呼吸病学年会——2013第十四次全国呼吸病学学术会议 年份：2013
Background It has been found that HGF-dependent c-Met (HGFR) autocrine is activated in a wide variety of human primary and second malignancies.On the other hand, the metastatic growth potential of tum...
[期刊论文] 作者：Ya CHEN,Yanan WANG,Zhengyu YANG,Minjuan HU,Yanwei ZHANG,Fangfei QIAN,Wei ZHANG,Bo ZHANG,Baohui HAN,王李强,
来源：中国肺癌杂志 年份：2022
目的 该研究旨在评估及比较帕博利珠单抗联合含铂化疗(pembrolizumab plus platinum-based chemotherapy,PC)或帕博利珠单抗单药治疗(pembrolizumab monotherapy,PM)对程序性死亡配体1(programmed death ligand 1,PD-L1)肿瘤比例评分(tumor proportion score,TP......
[会议论文] 作者：Baohui Han,Liwen Xiong,Jiayuan Sun,Rong Li,Yuqing Lou,Yanwei Zhang,Aiqing Gu,Liyan Jiang,Jianxin Shi,,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Background: Concurrent chemoradiation therapy or induction chemotherapy plus surgery were considered as standard treatment to non-small-cell lung cancer (NSCLC) in stage ⅢA-N2, but the side effect bec...
[会议论文] 作者：Huang,Meili Ma,Yuqing Lou,Yanwei Zhang,Lixia Wu,David w.Chang,Picheng Zhao,Qianggang Dong,Xifeng Wu,Baohui Han,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: Stem-like cells in solid tumors are purported to contribute to cancer development and poor treatment outcome.The abilities to self-renew, differentiate, and resist anticancer therapies are...
Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer p
[期刊论文] 作者：Liu,Minjuan Hu,Yuqing Lou,Yanwei Zhang,Zhiqiang Gao,Wei Zhang,Xueyan Zhang,Huimin Wang,Hua Zhong,Baohui Han,
来源：中国癌症研究（英文版） 年份：2022
Objective:Anti-vascular endothelial growth factor(VEGF)monoclonal antibodies are an effective means of treating non-small cell lung cancer(NSCLC).Here,we aim to update the equivalent efficacy assessment between QL1101 and bevacizumab based ......
相关搜索：
